| http://www.w3.org/ns/prov#value | - Tricyclic 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-??]pyridine derivatives as phosphodiesterase inhibitors useful for the treatment of an inflammatory condition, asthma, arthritis, bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, dermatitis as well as AIDS, septic shock and other diseases, such as cachexia, are disclosed in WO9639408 in the name of Pfizer Inc
|
